Trials / Completed
CompletedNCT01075204
Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 335 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to describe the time to recovery of symptoms (cough, mucus, fever, sore throat, and others), tolerability and compliance of treatment with clarithromycin once daily in patients with upper or lower respiratory tract infections in the routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clarithromycin modified release 500 mg | clarithromycin modified release 500 mg for 7 days |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-02-25
- Last updated
- 2013-02-12
- Results posted
- 2013-01-30
Locations
12 sites across 2 countries: Egypt, Saudi Arabia
Source: ClinicalTrials.gov record NCT01075204. Inclusion in this directory is not an endorsement.